Ces radiol. 2016, 70(2):65-71 | DOI: 10.55095/CesRadiol2016/010
Renal denervation in patiens with severe idiopatic difficult to control hypertensionOriginal article
- 1 Pracoviště diagnostické a intervenční radiologie IKEM, Praha
- 2 Klinika kardiologie IKEM, Praha
Aim: The aim of our study was to establish whether or not renal sympathetic denervation (RSD) may help control blood pressure (BP) levels in patients with severe hypertension refractory to pharmacological therapy.
Method: Out of a group of 12 patients, candidates for RSD, with uncontrolled hypertension (systolic BP over 190-200 mm Hg on repeated measurements despite optimal medication) four patients were excluded for multiple renal arteries and one for hyperaldosteronism. Seven patients had RSD using a Symplicity device (5 M, 2 F) with a mean age of 64.9 years. While all were followed up for a minimum of 6 months, follow-up duration in the majority of them was substantially longer (12-20 months).
Results: At six months post-RSD, six of the seven patients showed a decrease in systolic BP by at least 20 mm Hg while receiving the same or fewer doses of antihypertensive agents. A similar response was seen in diastolic BP. The BP decrease was maintained throughout whole follow-up.
Conclusion: In a small group of patients we demonstrated that renal sympathetic denervation is capable of reducing blood pressure even in patients with severe hypertension.
Keywords: blood pressure, hypertension, renal denervation
Grants and funding:
Podpořeno MZ ČR - RVO ("Institut klinické a experimentální medicíny - IKEM, IČ 00023001").
Accepted: April 5, 2016; Published: June 1, 2016 Show citation
References
- Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-1281.
Go to original source...
- Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patiens with treatment-resistant hypertension (the SYMPLICITY HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-1909.
Go to original source...
Go to PubMed...
- Kandzari DE, Bhatt DL, Sobotka PA, O Neill WW, Esler M, Flack JM, Katzen BT, Leon MB, Massaro JM, Negoita M, Oparil S, Rocha-Singh K, Straley C, Townsend RR, Bakris G. Catheter-based renal denervation for resistant hypertension: Rationale and design of the SYMPLICITY HTN-3. Clin Cardiol 2012; 35: 528-535.
Go to original source...
Go to PubMed...
- Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris G. A controlled trial of renal denervation for resistant hypertension N Engl J Med 2014; 370: 1393-1401.
Go to original source...
Go to PubMed...
- Sun RR, Lu L, Liu M, Cao Y, Li XC, Liu H, Wang J, Zhang PY. Biomarkers and heart diseas. Eur Rev Med Pharmacol Sc 2014; 18: 2927-2935.
- Mancia G, Fagard, R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, DeBacker G, Dominczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigmaa M, Waeber B, Zannad F. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
Go to original source...
Go to PubMed...
- DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11: 197-200.
Go to original source...
Go to PubMed...
- Katholi RE. Renal nerves and hypertension: An update. Fed Proc 1985; 44: 2846-2850.
- O'Hagan KP, et al. Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. Am J Hypertens 1990; 3: 62-64.
Go to original source...
Go to PubMed...
- Katholi RE, Winternitz SR, Oparil S. Role of renal nerves in the pathogenesis of one-kidney renal hypertension in the rat. Hypertension 1981; 3: 404-409.
Go to original source...
Go to PubMed...
- Katholi RE, Whitlow PL, Winternitz SR, Oparil S. Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. Hypertension 1982; 4: 166-174.
Go to original source...
- Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc 1953; 152: 1501-1504.
Go to original source...
Go to PubMed...
- Grimson KS, Orgain ES, Anderson B, Broome RA, Longino FH. Results of treatment of patients with hypertension by total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy. Ann Surg 1949; 129: 850-871.
Go to original source...
- Nathan S, Bakris GL. The future of renal denervation in resistant hypertension. Curr Hypertens Rep 2014; 16: 494-499.
Go to original source...
Go to PubMed...
- Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, Petzold M, Muller U, Schuler G, Eitel I, Thiele H, Lurz P. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension 2015; 65(6): 1202-1208.
Go to original source...
Go to PubMed...
- Azizi M, Sapoval M, Gossep P, Monge M, Bobrie G, Delsart P, Midulla M, Mournier-Véhier C, Courand, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G; Renal Denervation for Hypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 2015; 385(9981): 1957-1965.
Go to original source...
Go to PubMed...
- Ormiston JA, Watson T, van Pelt N, Stewart R, Stewart JT, White JM, Doughty RN, Stewart F, Macdonald R, Webster MW. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from Renal Hypertension Ablation Systém (RHAS) trial. Eurointervention 2013; 9: 70-74.
Go to original source...
Go to PubMed...
- Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor, M. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from REDUCE-HTN clicnical study. Eurointervention 2015; 10: 1213-1220.
Go to original source...
Go to PubMed...
- Tzafriri AR, Mahfoud F, Keating JH, Markham PM, Spognardi A, Wong G, Fuimaono K, Böhm M, Edelman ER. Innervation patterns may limit response to endovascular renal denervation. J Am Coll Cardiol 2014; 64: 1079-1087.
Go to original source...
- Lambert E, Straznicky N, Schlaich M, Esler M, Daywood T, Hotchkin E, Lambert G. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007; 50: 862-868.
Go to original source...
Go to PubMed...
- Middlekauf HR. A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in Symplicity HTN-3. J Am Coll Cardiol 2015; 65: 959.
Go to original source...
Go to PubMed...
- Reddy VY, Olin JW. Renal denervation for resistant hypertension, Not dead yet. J Am Coll cardiol 2014; 64: 1088-1091.
Go to original source...
Go to PubMed...
- Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambrt GW, Schlaich MP, May CN. Reinnervation following catheter-based radio-frequency renal denervation. Exp Physiol 2015; DOI: 10.1113/expphysiol.2014.079871.
Go to original source...
Go to PubMed...
- Stefanidis C, Synetos A, Tsioufis C, Drakopoulou M, Tsiamis E, Tousoulis D, Agrogiannis G, Patsouris E, Toutouzas K. Chemical renal denervation by vincristine: The role of the flow rate of delivery. Cardiovasc Intervent Radiol 2014; 37: 1336-1342.
Go to original source...
Go to PubMed...
- Stefanidis C, Toutouzas K, Vlachopoulos C, Tsioufis C, Synetos A, Pietri P, Tousoulis D, Tsiatis E. Chemical denervation of the renal artery with vincristine for the treatment of resistant arterial hypertension: first-in-man application. Hellenic J Cardiol 2013; 54: 318-321.
- Yuan M, Wang Q, Li C, Zhang H, Wang H, Zhang Y, Ren J. Adrenomedullin in vascular endothelial injury and combination therapy: time for a new paradigm. Curr Vasc Pharmacol 2014; DOI: 10.2174/1570161112666141014145735.
Go to original source...
Go to PubMed...
- Tenderenda-Banasiuk E, Wasilewska A, Filonowicz R, Jakubowska U, Waszkiewicz-Stojda M. Serum copepetin in adolescent with primary hypertension. Pediatr Nephrol 2014; 29: 423-429.
Go to original source...
Go to PubMed...
- Yeung EH, Liu A, Mills JL, Zhang C, Männistö T, Lu Z, Tsai M, Mendola P. Increased levels of copeptin before clinical diagnosis of preeclampsia. Hypertension 2014; 64: 1362-1367.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.